Cargando…
Epimedin C protects dexamethasone-induced osteoblasts through NRF1/RhoA pathway
Osteoporosis (OP) is a metabolic bone disease that leads to decrease of bone strength and increase bone brittle and fracture. Dexamethasone (DXMS) usage is a common risk factor of OP. In present study, we found that the Epimedin C protect the DXMS-induced OP, Ras Homolog Family Member A transforming...
Autores principales: | Huang, Mi, Yu, Lei, Wang, Ying, Yang, Chunlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085613/ https://www.ncbi.nlm.nih.gov/pubmed/36920182 http://dx.doi.org/10.18632/aging.204588 |
Ejemplares similares
-
RhoA improves cryopreservation of rooster sperm through the Rho/RhoA-associated kinase/cofilin pathway
por: Heng, Nuo, et al.
Publicado: (2022) -
Development of epimedin A complex drugs for treating the osteoporosis
por: Liu, Ying, et al.
Publicado: (2021) -
Comparative Pharmacokinetics and Bioavailability of Epimedin C in Rat after Intramuscular Administration of Epimedin C, a Combination of Four Flavonoid Glycosides and Purified Herba Epimedii Extract
por: Xu, Shunjun, et al.
Publicado: (2016) -
The role of RhoA/Rho kinase pathway in endothelial dysfunction
por: Yao, Lin, et al.
Publicado: (2010) -
NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction
por: Zhang, Chao, et al.
Publicado: (2016)